DoH HTA project with the Health Economics Research Group, Brunel University, assessing the effectiveness and cost effectiveness of the management of stable angina.
The economics of SDD in intensive care.
The use of proxy cost meaures to obtain accurate costs associated with individual patients on intensive care.
Cost effectiveness of alternative anaesthetic agents and techniques in day surgery is being developed with the University Department of Anaesthesia, the School of Epidemiology and the Centre for Health Economics at York University.
Economic implications of nurse-led ophthalmic surgery with the School of Nursing Studies
Educational research assessed the use of health economics by LPC members after health economics study days.
Undergraduate pharmacy students:
Postgraduate pharmacy students (Msc/Diploma in Clinical and Health Services Pharmacy):
Postgraduate nursing students
1988 B.Pharm Honours in Pharmacy: Second Class; upper division (Bath)
Royal Pharmaceutical Society of Great Britain
Brief Career Details
1996- Clinical lecturer in pharmacy, School of Pharmacy and Pharmaceutical Sciences, University of Manchester, (full time employee of University of Manchester, 25% time at Manchester Royal Infirmary, probation ends July 1999)
Jan-Mar 1996 Research fellow, Health Economics Research Group, Brunel University.
1994 -1996 Contract health economist to Battelle Medtap, Wyeth and Zeneca Pharmaceuticals.
Dec 1995 Charing Cross Hospital Pharmacy Department, London. Acting manager, non-sterile manufacturing unit
1992-1995 PhD student Brunel University, Health Economics Research Group, supervised by Professor Martin Buxton. (thesis concerning the economic evaluation of critical care medicine, sponsored by the Department of Health Pharmacy Practice Research Enterprise Scheme, completed Nov 1995, awarded Jan 1996)
1989 -1992 Charing Cross Hospital Pharmacy Department, London, Locum pharmacist, ad hoc hours.
1990 -1992 Charing Cross Hospital Pharmacy Department, London, Resident and clinical specialist (intensive care) pharmacist
Elliott R., Hanney S. Case Study Eight: Outcome comparisons of intensive care units in Great Britain and Ireland using the APACHE II method. In: Buxton M., Hanney S. (1994). Assessing Payback from Department of Health Research and Development: Preliminary Report (Vol. 2).
Elliott R. Secondary economic analysis in intensive care: the case of selective decontamination of the digestive tract. HERG discussion paper no 13 (April 1995).
Elliott R. Economic evaluation in intensive care: the case of SDD [PhD thesis] (1995).
Elliott R. An analysis of drug costs for the management of chemotherapy-related side effects in advanced colorectal cancer. Journal of Oncology Pharmacy Practice 1996; 2: 186-190.
Elliott R., Payne K., Silcock J. Health economics: Do or be done by. Pharmaceutical Journal 1996; 257: 832.
Elliott R. Economic analysis of SDD in intensive care using a decision-analytic model, paper presented at Health Services Research and Pharmacy Practice Conference, 1996, Manchester
Elliott R, Payne K, Silcock J. Prove the value of pharmacy. Pharmacy in Practice 1997; July/August: 349-350
Silcock J, Elliott R, Payne K. Evaluate primary care. Pharmacy in Practice 1997; September: 405-418
Payne K, Silcock J, Elliott R. Economics aids formulary choice Pharmacy in Practice 1997: October; 478-491
Elliott R. Pharmacoeconomics. In: Clinical Pharmacists Survival Guide, Edited by Nick Barber, Published by: Churchill Livingstone. In print.
Elliott R. The case for bottom-up drug costs for intensive care patients: a study of two British intensive care units, paper presented at Health Services Research and Pharmacy Practice Conference, 1997, London
Elliott R. Economic analysis of selective decontamination of the digestive tract in intensive care. Pharmaceutical Journal 1997; 259: R30.
Petticrew M, Sculpher M, Kelland J, Elliott R, Holdright D, Buxton M. Review of chronic stable angina. NHS R&D Report. Final report submitted 1997.
© 2001 School of Pharmacy and Pharmaceutical Sciences, University of Manchester